Aims: The universal definition of myocardial infarction (MI) classifies acute ischaemia into different classes according to lesion mechanism. Our aim was to perform a detailed comparison between these different types of MI in terms of baseline characteristics, management and prognosis. Methods and Results: An observational retrospective single-centre cohort study was performed, including 1,000 consecutive patients admitted for type 1 (76.4%) or type 2 MI (23.6%). Type 2 MI patients were older, had a higher prevalence of comorbidities and worse medical status at admission. In-hospital mortality did not differ significantly between the MI groups (8.8 vs. 9.7%, p = 0.602). However, mortality during follow-up was almost 3 times higher in type 2 MIs (HR 2.75, p < 0.001). Type 2 MI was an independent all-cause mortality risk marker, adding discriminatory power to the GRACE model. Finally, important differences in traditional risk score performances (GRACE, CRUSADE) were found between both MI types. Conclusions: Several important baseline differences were found between these MI types. Regarding prognosis, long-term survival is significantly compromised in type 2 MIs, potentially translating patients' higher medical complexity and frailty. Distinction between type 1 and type 2 MI seems to have important implications in clinical practice and likely also in the results of clinical trials.

1.
Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases. Part II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-2864.
[PubMed]
2.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction: Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-2256.
[PubMed]
3.
Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C: High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012;33:579-586.
[PubMed]
4.
Leonardi SL, Newby K, Ohman EM, Armstrong PW: Lack of implementation of ESC/ACC definition of myocardial infarction in contemporary randomized clinical trials. Circulation 2010;122:A11021.
5.
Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS, Paterson E, MacLeod M, Graham C, Walker S, Denvir MA, Fox KA, Newby DE: Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-1216.
[PubMed]
6.
Meier MA, Al-Badr WH, Cooper JV, Kline-Rogers EM, Smith DE, Eagle KA, Mehta RH: The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 2002;162:1585-1589.
[PubMed]
7.
Costa FM, Ferreira J, Aguiar C, Dores H, Figueira J, Mendes M: Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years. Eur Heart J 2012;33:2544-2550.
[PubMed]
8.
Fox A, Eagle K, Gore J, Steg G, Anderson F, GRACE Investigators: The global registry of acute coronary events, 1999 to 2009 - GRACE. Heart 2010;96:1095-1101.
[PubMed]
9.
Hoekstra JW, Pollack CV Jr, Roe MT, Peterson ED, Brindis R, Harrington RA, Christenson RH, Smith SC, Ohman EM, Gibler WB: Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med 2002;11:1146-1155.
[PubMed]
10.
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW: Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344.
[PubMed]
11.
Lamb EJ, Tomson CR, Roderick PJ: Estimating kidney function in adults using formulae. Ann Clin Biochem 2005;42:321-345.
[PubMed]
12.
Hamm CW, Bassand JP, Agewall S, et al: ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
[PubMed]
13.
Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ‘t Hof A, Widimsky P, Zahger D: ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
[PubMed]
14.
Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL: Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 2011;12:167-205.
[PubMed]
15.
Kokotailo RA, Hill MD: Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005;36:1776-1781.
[PubMed]
16.
Thygesen K, Alpert JS, White HD, et al: Universal definition of myocardial infarction. Circulation 2007;116:2634-2653.
[PubMed]
17.
Gaetano L: The universal definition of myocardial infarction: some issues and concerns. Eur Heart J 2008;29:1209.
[PubMed]
18.
Saaby L, Poulsen TS, Hosbond S, Larsen TB, Diederichsen AC, Hallas J, Thygesen K, Mickley H: Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789-797.
[PubMed]
19.
Javed U, Aftab W, Ambrose J, Wessel RJ, Mouanoutoua M, Huang G, Barua RS, Weilert M, Sy F, Thatai D: Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9-13.
[PubMed]
20.
Melberg T, Burman R, Dickstein K: The impact of the 2007 ESC-ACC-AHA-WHF universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 2010;139:228-233.
[PubMed]
21.
Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA: American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38. Circulation 2012;125:577-583.
[PubMed]
22.
Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A: 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2014;35:2541-2619.
[PubMed]
23.
Leonardi SL, Newby K, Ohman EM, Armstrong PW: Lack of implementation of ESC/ACC definition of myocardial infarction in contemporary randomized clinical trials. Circulation 2010;122:A11021.
24.
Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RS, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL: Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med 2009;361:2318-2329.
[PubMed]
25.
White HD, Chew DP, Dauerman HI, Mahaffey KW, Gibson CM, Stone GW, Gruberg L, Harrington RA, Bhatt DL: Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. Am Heart J 2012;163:182-190.
[PubMed]
You do not currently have access to this content.